Marshall Wace, LLP’s Eli Lilly & Co Position
Does Marshall Wace, LLP own Eli Lilly & Co (LLY)? Yes — 576.2K shares worth $530M (+0.53% of its 13F portfolio) as of Q1 2026, down from 1.21M shares the prior filed quarter.
Position Value
$530M
Q1 2026
Shares
576.2K
% of Portfolio
+0.53%
Quarters Held
25
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 576.2K | $530M | +0.53% |
| Q4 2025 | 1.21M | $1.3B | +1.18% |
| Q3 2025 | 163.1K | $124M | +0.13% |
| Q2 2025 | 931.7K | $726M | +0.82% |
| Q1 2025 | 419.5K | $346M | +0.44% |
| Q4 2024 | 388.7K | $300M | +0.36% |
| Q3 2024 | 910.1K | $806M | +0.98% |
| Q2 2024 | 789.6K | $715M | +0.95% |
| Q1 2024 | 423.3K | $329M | +0.50% |
| Q4 2023 | 720.5K | $420M | +0.71% |
| Q3 2023 | 594.1K | $319M | +0.65% |
| Q2 2023 | 96.4K | $45M | +0.09% |
| Q1 2023 | 689.1K | $237M | +0.50% |
| Q4 2022 | 136.0K | $50M | +0.11% |
| Q3 2022 | 400.2K | $129M | +0.28% |
| Q2 2022 | 1.13M | $367M | +0.76% |
| Q4 2021 | 2.1K | $591,000 | 0.00% |
| Q3 2021 | 153.9K | $36M | +0.15% |
| Q2 2021 | 94.3K | $22M | +0.10% |
| Q1 2021 | 20.2K | $4M | +0.02% |
| Q4 2020 | 212.2K | $36M | +0.19% |
| Q3 2020 | 185.0K | $27M | +0.18% |
| Q2 2020 | 163.1K | $27M | +0.19% |
| Q1 2020 | 9 | $1,000 | 0.00% |
| Q4 2019 | 5 | $1,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marshall Wace, LLP’s full portfolio or all institutional holders of LLY.